Advertisement
Table 5 Group B (Versapoint®) demographic characteristics, type and size of myomas, and associated hysteroscopic findings and symptoms
| No. of patients | 51 |
|---|---|
| No. of myomas | 56 |
| Age, mean ± SD (95 % CI), years | 48.04 ± 11.4 (44.8–51.3) |
| Parity, no. (%) | |
| Nulliparous | 23. (45.1) |
| Pluriparous | 28 (54.9) |
| Sub mucous myomas, no. (%) | |
| 1 | 46 (90.2 %) |
| > 1 | 5 (9.8 %) |
| Myoma size, mm | |
| Principal myoma, mean ± SD (95 % CI) | 25.2 ± 14.6 (21.1–29.3) |
| Second myoma, mean ± SD (95 % CI) | 20.8 ± 12.1 (18.7–24.9) |
| Type of principal myoma, no. (%) | |
| Wamsteker classification | |
| G0 18 (32.1) | |
| G1 18 (32.1) | |
| G2 20 (35.8) | |
| Associated hysteroscopic findings, no. (%) | |
| None | 45 (88.2) |
| Polyp | 6 (11.8) |
| Synechiae | 0 (0) |
| Symptoms, no. (%)a | |
| None | 27 (52.9) |
| Menorrhagia | 12 (23.5) |
| Infertility | 6 (11.7) |
| Pelvic pain | 6 (11.7) |
